Active Shortage

TEVA-EMTRICITABINE/TENOFOVIR

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TEVA-EMTRICITABINE/TENOFOVIR in Canada?

Yes. TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG has an active shortage reported to Health Canada (last updated April 9, 2026).

Why is TEVA-EMTRICITABINE/TENOFOVIR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will TEVA-EMTRICITABINE/TENOFOVIR be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength300MG 200MG

Last updated2026-04-09

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02399059

Strength

300MG 200MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE

Tier

Unrated

Last Updated

2026-04-09

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163